Sanofi’s Insulin Aspart Biosimilar Gets European Nod

As Accord’s Cabazitaxel And Fingolimod Are Endorsed By CHMP

 
• By David Wallace
  
Insulin
Sanofi’s insulin aspart received a positive CHMP opinion • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products